Palliative Care Effects on Survival in Glioblastoma: Who Receives Palliative Care?

Oronsky, 2021, A review of newly diagnosed glioblastoma, Front Oncol, 10, 574012, 10.3389/fonc.2020.574012 Stupp, 2010, High-grade malignant glioma: ESMO clinical practice guidelines for diagnosis, treatment and follow-up, Ann Oncol, 21, v190, 10.1093/annonc/mdq187 Ostrom, 2021, CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2014-2018, Neuro Oncol, 23, iii1, 10.1093/neuonc/noab200 Ostrom, 2015, CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2008-2012, Neuro Oncol, 17, iv1, 10.1093/neuonc/nov189 Oike, 2013, Radiotherapy plus concomitant adjuvant temozolomide for glioblastoma: Japanese mono-institutional results, PLoS One, 8, 6, 10.1371/journal.pone.0078943 Ståhl, 2020, Health-related quality of life and emotional well-being in patients with glioblastoma and their relatives, J Neurooncol, 149, 347, 10.1007/s11060-020-03614-5 Ostrom, 2013, CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2006-2010, Neuro Oncol, 15 Crooms, 2020, Palliative care in high-grade glioma: a review, Brain Sci, 10, 723, 10.3390/brainsci10100723 Al-Mahrezi, 2016, Palliative care: time for action, Oman Med J, 31, 161, 10.5001/omj.2016.32 Murphy, 2017, Effect of palliative care on aggressiveness of end-of-life care among patients with advanced cancer special series: palliative care original contribution special series: palliative care original contribution associated content effect of palliative care on, J Oncol Pract, 13, e760, 10.1200/JOP.2017.020883 Ferrell, 2017, Integration of palliative care into standard oncology care: American society of clinical oncology clinical practice guideline update, J Clin Oncol, 35, 96, 10.1200/JCO.2016.70.1474 Walid, 2008, Prognostic factors for long-term survival after glioblastoma, Perm J, 12, 45, 10.7812/TPP/08-027 Boffa, 2017, Using the national cancer database for outcomes research: a review, JAMA Oncol, 3, 1722, 10.1001/jamaoncol.2016.6905 Bilimoria, 2009, Comparison of commission on cancer-approved and -nonapproved hospitals in the United States: implications for studies that use the National Cancer Data Base, J Clin Oncol, 27, 4177, 10.1200/JCO.2008.21.7018 Mohanty, 2014, Comparing national cancer registries: the national cancer data base (NCDB) and the surveillance, epidemiology, and end results (SEER) program, J Surg Oncol, 109, 629, 10.1002/jso.23568 Patel, 2022, Factors associated with palliative intervention utilization for metastatic renal cell carcinoma, Clin Genitourin Cancer, 20, 296, 10.1016/j.clgc.2022.01.001 Islam, 2021, Racial disparities in palliative care utilization among metastatic gynecological cancer patients living at last follow-up: an analysis of the National Cancer Data Base, Data Brief, 34, 106705, 10.1016/j.dib.2020.106705 American College of Surgeons. National cancer database participant user file 2020 data dictionary. Available at: https://www.facs.org/media/brilfbgu/puf-2020-data-dictionary.pdf, 2021. Accessed June 19, 2022. Grochans, 2022, Epidemiology of glioblastoma multiforme-literature review, Cancers (Basel), 14, 2412, 10.3390/cancers14102412 Efremov, 2021, Patterns of glioblastoma treatment and survival over a 16-years period: pooled data from the German Cancer Registries, J Cancer Res Clin Oncol, 147, 3381, 10.1007/s00432-021-03596-5 Song, 2009, Genetic epidemiology of glioblastoma multiforme: confirmatory and new findings from analyses of human leukocyte antigen alleles and motifs, PLoS One, 4, e7157, 10.1371/journal.pone.0007157 Gofton, 2012, Identifying the palliative care needs of patients living with cerebral tumors and metastases: a retrospective analysis, J Neuro Oncol, 108, 527, 10.1007/s11060-012-0855-y Forst, 2018, Hospice utilization in patients with malignant gliomas, Neuro Oncol, 20, 538, 10.1093/neuonc/nox196 Minniti, 2019, Glioblastoma in elderly patients: current management and future perspectives, Cancers, 11, 1, 10.3390/cancers11030336 Nikolich-Žugich, 2018, The twilight of immunity: emerging concepts in aging of the immune system review-article, Nat Immunol, 19, 10, 10.1038/s41590-017-0006-x Ladomersky, 2019, The coincidence between increasing age, immunosuppression, and the incidence of patients with glioblastoma, Front Pharmacol, 10, 1, 10.3389/fphar.2019.00200 Nakanjako, 2022, Health Service delivery and training at Makerere University College of Health Sciences: the role of the academic health centers’ network, Afr Health Sci, 22, 63, 10.4314/ahs.v22i2.10S Ronning, 2012, A population-based study on the effect of temozolomide in the treatment of glioblastoma multiforme, Neuro Oncol, 14, 1178, 10.1093/neuonc/nos153 Fabbro-Peray, 2019, Association of patterns of care, prognostic factors, and use of radiotherapy–temozolomide therapy with survival in patients with newly diagnosed glioblastoma: a French national population-based study, J Neuro Oncol, 142, 91, 10.1007/s11060-018-03065-z Hansen, 2018, Treatment and survival of glioblastoma patients in Denmark: the Danish Neuro-Oncology Registry 2009–2014, J Neuro Oncol, 139, 479, 10.1007/s11060-018-2892-7 Golla, 2020, Effect of early palliative care for patients with glioblastoma (EPCOG): a randomised phase III clinical trial protocol, BMJ Open, 10, e034378, 10.1136/bmjopen-2019-034378 Mann, 2003, Observational research methods. Research design II: cohort, cross sectional, and case-control studies, Emerg Med J, 20, 54, 10.1136/emj.20.1.54 Hauck, 1998, Should we adjust for covariates in nonlinear regression analyses of randomized trials?, Control Clin Trials, 19, 249, 10.1016/S0197-2456(97)00147-5